Skip to main content

Talis Biomedical Corporation (NASDAQ: TLIS) Investor Securities Class Action Lawsuit 01/07/2022

  • If you purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS), you have certain options and for certain investors are short and strict deadlines running. Deadline: March 8, 2021. NASDAQ: TLIS investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 7, 2022 - An investor in shares of Talis Biomedical Corporation (NASDAQ: TLIS) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Talis Biomedical Corporation in connection with certain allegedly false and misleading statements made in connection with the Company’s February 2021 initial publi...



You must register (for free) or login to view the entire case.